2016 Speakers and Participants
- Wade Ackerman, Partner, Covington & Burling LLP
- Karen Akinsanya, PhD, Associate Vice President, Head, Early Stage Scientific Assessment, Merck
- Franklin M. Berger, CFA, Managing Director, FMB Research
- Laurence Blumberg, MD, Founder & Chief Operating Officer, Syntimmune, Inc.
- Jeffrey M. Bockman, PhD, Vice President, Defined Health
- Jarrod Borkat, MBA, Senior Director, Head of External Collaborations and Government Contracts, MedImmune LLC
- Keith A. Bostian, PhD, Chief Executive Officer, Institute for Life Science Entrepreneurship (ILSE)
- Scott P. Bruder, MD, PhD, Bruder Consulting International, LLC
- Chris Cain, PhD, Associate, Appletree Partners
- Stephen Chang, PhD, Senior Vice President for Strategic Initiatives, The New York Stem Cell Foundation
- Hina W. Chaudhry, MD, Associate Professor of Medicine, Director, Cardiovascular Regenerative Medicine, Mount Sinai School of Medicine
- Ellen B. Corenswet, Partner, Covington & Burling LLP
- Kate de Santis, Vice President of Investor Relations Iroko Pharmaceuticals, LLC
- Christopher de Souza, PhD, MBA, Director, Broadview Ventures, Inc.
- Eleanor “Ellie” Dehoney, Vice President, Policy and Advocacy, Research!America
- Peter DeLuca, MS, Partner, Carter, DeLuca, Farrell & Schmidt, LLP
- Kenneth Emancipator, MD, Executive Medical Director and Head, Companion Diagnostics, Merck Research Laboratories
- Rebecca Farkas, PhD, Associate Director for Strategic Collaborations, MedImmune
- David Filer, PhD,Advisor, SternAegis Ventures
- Christine Fischette, PhD, Advisor, Torreya Partners
- Stephanie Fertig, MBA, Director, NINDS Small Business Programs, National Institute of Neurological Disorders and Stroke, National Institutes of Health
- Thomas Gallagher, Principal, Fenagh Group
- Kaushik Ghosal, PhD, Director of Business Development, BioMotiv
- Edwin H. Gordon, MBA, Co-Head of Healthcare Investment Banking, Ladenburg Thalmann
- Sherry Grisewood, CFA, Managing Partner, Life Science Research, Dawson James Securities
- Joseph V. Gulfo, MD, MBA, Executive Director of the Lewis Center for Healthcare Innovation and Technology at Fairleigh Dickinson University
- Dario A. Gutierrez, PhD, Immuno-biology Lead, Merck Research Labs- Cambridge Exploratory Science Center
- Kimberly Ha, Senior Director, FTI Consulting
- Todd Haim, PhD, Program Director, SBIR Development Center, National Cancer Institute, National Institutes of Health
- Dov Hass, Director, Transactions and Corporate Law, Regeneron Pharmaceuticals
- Kenton C. Hasson, PhD, Senior Manager, Business Development & Innovation, Canon BioMedical
- William G Hearl, PhD, Chief Executive Officer, Immunomic Therapeutics, Inc.
- Cláudia Hirawat, Independent BD Consultant & Advisor
- Paul Howard, Senior Fellow, Director, Health Policy, Manhattan Institute
- Nouhad Husseini, MBA, Senior Director, Business Development, Regeneron Pharmaceuticals
- Stefan Irion, MD, Program Manager, New York State Stem Cell Science Consortia, Memorial Sloan Kettering Cancer Center
- Stuart Jacobowitz, Director of Business Development, FreeMind Group
- Anna Kazanchyan, MD, Founder & CEO, Saghmos Therapeutics Inc.
- Pavel Khrimian, Associate Director, External Collaborations and Diagnostics Business Development, MedImmune LLC
- Kevin Koch, PhD, Venture Partner, Orbimed
- Kristen Kosofsky, Senior Managing Director, Hercules Technology Capital
- Steven Kreit, Partner, EisnerAmper
- Joan Kutcher, Of Counsel, Covington & Burling, LLP
- Jennifer LaVin, MBA, Principal SMP Communications
- Douglas W. Losordo, MD, FACC, FAHA, Senior Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer, Caladrius Biosciences
- Ellen Lubman, MBA, Vice President, External Science & Innovation, Allergan PLC
- Sanford J. Madigan, PhD, Senior Vice President, COI Pharmaceuticals, Inc.
- Michael Marino, PhD, Manager, GE Global Research
- Stephen Nagler, Executive Director, MedPro Investors LLC
- Marian T. Nakada, PhD, Vice President Venture Investments, Johnson & Johnson Innovation – JJDC Inc.
- Ron Newbold, MS, MBA, PhD, Vice President, External R&D Innovation – Head Global Scouting, Pfizer
- Bernat Olle, PhD, Co-Founder, Chief Executive Officer, Vedanta Biosciences
- Brian P. O’Shaughnessy, Shareholder, RatnerPrestia; President-elect of Licensing Executives Society (LES). (USA & Canada)
- Art Pappas, MBA, Managing Partner, Pappas Ventures
- Ronit Phail, PhD, Sr. Director, External Innovation, Corporate Business Development, Eli Lilly and Company
- Bill Podd, President, Landmark Angels and Landmark Family Office
- Dennis J. Purcell, Founder and Senior Advisor, Aisling Capital LLC
- Alexander S. Preker, President & CEO, Health Investment & Financing Corporation
- Barbara S. Schilberg, Managing Director and Chief Executive Officer, BioAdvance
- Bavani Shankar, MBA, Senior Director, Business Development, Scientific Partnering & Alliances, AstraZeneca
- Boris Shor, Life Sciences Investment Advisor, Primer Capital
- Mark Simon, MBA, Partner, Torreya Partners
- Bryan C. Spielman, Executive Vice President, Strategy and Corporate Development, Seven Bridges
- Kathryn Stein, PhD, Principal, Kathryn Stein Consulting (Former Director, Division of Monoclonal Antibodies, FDA)
- Gregory Q. Tiberend, President & CEO, Tiberend Strategic Advisors, Inc.
- Stephen H. Tsang, MD, PhD, Associate Professor in Pathology & Cell Biology, László Bitó Associate Professor in Ophthalmology, Columbia University
- Felicia Vonella, Executive Director, Investor Relations & Corporate Communications, Acorda Therapeutics
- Geoffrey von Maltzahn, PhD, VentureLabs Partner, Flagship Ventures
- Anton Xavier, MS, MBA, NY/NYC Biotech Scout, Targeted Therapeutics Discovery, Pfizer WRD
- Peter Young, Executive-in-Residence, Pappas Ventures
- Tingting Zhang-Kharas, PhD, Advisor – Oncology External Innovation, Eli Lilly and Company
- Alex Zisson, Managing Director, H.I.G. Capital
View a list of our 2015 speakers
